ABSTRACT
The effects of the natural avermectin complex, aversectin C and individual avermectin B1 on the growth of ascitic and solid transplantable tumors in animals were studied. The results showed for the first time that both aversectin C and avermectin B1 possessed marked antitumor activity. In subtoxic doses aversectin C significantly inhibited the growth of P388 lymphoid leukemia and Ehrlich carcinoma, both ascitic and solid ones. In some administration regimens aversectin C inhibited the tumor growth by 70 to 80%. The highest effect of aversectin C was observed after its intraperitoneal administration. Avermectin B1 inhibited the growth of solid Ehrlich carcinoma and carcinoma 755.
Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Ehrlich Tumor/drug therapy , Ivermectin/analogs & derivatives , Ivermectin/pharmacology , Leukemia P388/drug therapy , Administration, Oral , Animals , Antineoplastic Agents/administration & dosage , Carcinoma, Ehrlich Tumor/pathology , Cell Proliferation/drug effects , Drug Screening Assays, Antitumor , Injections, Intraperitoneal , Injections, Subcutaneous , Ivermectin/administration & dosage , Leukemia P388/pathology , Male , MiceSubject(s)
Apoptosis/drug effects , Oligomycins/pharmacology , Animals , Cell Cycle/drug effects , Cell Line, Tumor , Cell Survival/drug effects , DNA Fragmentation/drug effects , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Leukemia P388/pathology , Male , Mice , Mice, Inbred DBA , Rats , Rats, Wistar , Thymus Gland/cytology , Thymus Gland/drug effectsABSTRACT
A natural avermectin complex, aversectin C, was shown to be capable of exerting selective cytostatic effect. It killed proliferating neuroblastoma B 103 cells but was non-toxic for differentiated cells of this culture. The activity of aversectin C was related neither to activation of the GABA alpha-receptors nor to their blocking and was at a large extent due to the action of avermectin A1, a component of aversectin C.
Subject(s)
Antibiotics, Antineoplastic/pharmacology , Ivermectin/pharmacology , Animals , Antibiotics, Antineoplastic/toxicity , Cell Death , Cell Differentiation , Cell Division , Ivermectin/analogs & derivatives , Ivermectin/toxicity , Rats , Tumor Cells, CulturedABSTRACT
A natural complex of avermectins, aversectin C, and a component of this complex, avermectin A1, were shown to change the conductivity of Ca(2+)-dependent chloride channels of plasmalemma of Chara corallina cells by acting only from the outer side of the cellular membrane. Low concentrations of aversectin C and avermectin A1 increased the chloride current: K1/2 = 3.5 x 10(-5) mg/ml for the whole complex and K1/2 = 2.1 x 10(-3) mg/ml for A1. Relatively high concentrations of the compounds suppressed the chloride current: K1/2 = 2.2 x 10(-3) mg/ml for aversectin C and K1/2 = 4.2 x 10(-6) mg/ml for A1. The Hill coefficients for the interaction of avermectin A1 with the corresponding targets for stimulation and suppression of the chloride current were 2.8 and 2.5 respectively. Bicuculine, a non-specific inhibitor of the GABA alpha-receptors, did not influence stimulation of chloride currents caused by action of low concentrations of avermectins, but at the same time blocked suppression of the chloride currents associated with the action of high doses of avermectins. Avermectins A2, B1 (abamectin), B2 and 22,23-dihydroavermectin B1 (vermectin) in the concentration range studied, did not affect the chloride currents of Chara corallina cells.
Subject(s)
Calcium/metabolism , Cell Membrane/physiology , Chloride Channels/drug effects , Chlorides/metabolism , Ivermectin/pharmacology , Chloride Channels/metabolism , Chlorides/physiology , Dose-Response Relationship, Drug , Electrophysiology , Eukaryota , Ivermectin/analogs & derivatives , Patch-Clamp TechniquesABSTRACT
A natural complex of avermectins, aversectin C, and a component of this complex, avermectin A1, were shown to change the conductivity of Ca2+-dependent Cl- channels of plasmalemma of Chara corallina cells by acting from the outer side of the cellular membrane. Low concentrations of aversectin C and avermectin A1 increased the Cl- current: K1/2 = 35 ng/ml for the whole complex and K1/2 = 21 pg/ml for A1. Relatively high concentrations of the compounds suppressed the Cl- current: K1/2 = 2.2 microg/ml for aversectin C and K1/2 = 4.2 ng/ml for A1. The Hill coefficient for the interaction of avermectin A1 with the corresponding targets was identical for stimulation and suppression of the Cl- current: 2.8 and 2.5, respectively. Bicuculline, a nonspecific inhibitor of the GABAa receptors, did not influence stimulation of Cl- currents caused by low concentrations of avermectins, but at the same time blocked suppression of the Cl- currents by high concentrations of avermectins. Avermectins A2, B1, B2, abamectin and 22,23-dihydroavermectin B1 (ivermectin) did not affect the Cl- currents of Chara corallina cells.
Subject(s)
Calcium/metabolism , Cell Membrane/physiology , Chloride Channels/drug effects , Chlorides/metabolism , Ivermectin/pharmacology , Chloride Channels/metabolism , Chlorides/physiology , Dose-Response Relationship, Drug , Electrophysiology , Eukaryota , Ivermectin/analogs & derivatives , Patch-Clamp TechniquesABSTRACT
Effect of natural avermectin complex (aversectin C) and separate avermectins A1, A2, B1 and B2 in the cell culture of murine myeloma Ns/o, Erlich carcinoma ascites and human larynx carcinoma Hep-2 was investigated. It was shown that aversectin C within the concentrations of 0.1 to 1.0 mcg/ml inhibited proliferation of tumor cells and induced their death. Proliferation inhibition was due to the delay of the cells cycle start (lag-phase prolongation) and blocking of mitotic cycle. Ns/o cells death had apoptosis signs: chromatin condensation and fragmentation, DNA fragmentation. It was demonstrated that only avermectin A1 has cytotoxic activity within the concentrations used, avermectins A2 and B2 had cytostatic activity, avermectin B1 showed no activity under the experimental conditions.
Subject(s)
Antibiotics, Antineoplastic/pharmacology , Ivermectin/analogs & derivatives , Ivermectin/pharmacology , Animals , Carcinoma, Ehrlich Tumor , Cell Division/drug effects , Humans , Laryngeal Neoplasms , Mice , Multiple Myeloma , Neoplasms, Glandular and Epithelial , Tumor Cells, CulturedABSTRACT
Avermectins are final products in the fermentation process with Streptomyces avermitilis. They have parasitocidic activity and are used as the main substances of insectoacaronematocides. The study of the activity of the natural avermectin complex (aversectin C) and separate avermectins A1, A2, B1 and B2 in the cell culture of lymphoid leukemia P-388 showed that within the concentrations of 0.1 to 1.0 microgram/ml aversectin C inhibited the growth of the tumor cells and induced their death. The inhibition was due to blocking the cell mitosis. The cell death was accompanied by internucleosomal degradation of the DNA nuclei i.e. the death was of the apoptosis type. The sensitivity of the cells to aversectin C was directly proportional to their initial proliferative activity. As for the separate avermectins only avermectin A1 had the cytotoxic activity within the concentrations used, avermectin A2 had the cytostatic activity and avermectins B1 showed no activity under the experimental conditions.
Subject(s)
Antineoplastic Agents/therapeutic use , Antiparasitic Agents/therapeutic use , Insecticides/therapeutic use , Ivermectin/analogs & derivatives , Leukemia, Lymphoid/drug therapy , Streptomyces/metabolism , Animals , Drug Screening Assays, Antitumor , Ivermectin/therapeutic use , Male , Mice , Mice, Inbred DBA , Tumor Cells, CulturedABSTRACT
A natural avermectin complex, aversectin C, was shown to be capable of exerting selective cytostatic and neurotoxic effects on mammalian cells. Specifically, it killed proliferating neuroblastoma B103 cells but was non-toxic for differentiated cells of this culture. The antiproliferation action of aversectin C was not inhibited by bicuculline or picrotoxin, antagonists of the GABAalpha receptors, and was partly due to the action of avermectin A1, a component of aversectin C. Aversectin C irreversibly suppressed activity of 60% neurons in medial septal slices of the rat brain. More than 55% of them were the GABAalpha- and B1-sensitive neurons whereas the rest, about 45% neurons, were the GABAalpha-insensitive and the neurotoxic effect of aversectin C was caused mainly by the B2 component.